Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities:
Net loss	$ (1,064,437)	$ (1,135,684)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization of property and equipment	298,973	161,961
Amortization of intangible assets	457,265	23,010
Amortization of other assets	56,433	92,323
Amortization of building capital lease	188,950	188,950
Gain on sale of property and equipment	(7,002)	(19,252)
Stock-based compensation expense	211,747	171,798
Change in allowance for doubtful accounts receivable	(1,561)	70,650
Change in allowance for inventory obsolescence	162,528	7,028
Deferred gain on sale/leaseback	(112,836)	(112,836)
Change in operating assets and liabilities:
Receivables, net	324,838	509,154
Inventories, net	(1,017,052)	(793,101)
Prepaid expenses	(124,079)	35,722
Other assets	(16,181)	(205,570)
Income tax payable	(3,896)	(3,967)
Accounts payable and accrued expenses	750,894	255,194
Net cash provided by (used in) operating activities	104,584	(754,620)
Cash flows from investing activities:
Purchase of property and equipment	(131,040)	(164,181)
Net cash paid in acquisition, net of cash received - see Note 2	(9,063,017)	0
Proceeds from sale of property and equipment	12,160	32,000
Net cash used in investing activities	(9,181,897)	(132,181)
Cash flows from financing activities:
Principal payments on long-term debt	(106,840)	(42,561)
Principal payments on long-term capital lease	(144,345)	(136,513)
Payment of acquisition holdbacks	(294,744)	2,540,073
Net change in line of credit	4,370,755	928,554
Proceeds from issuance of preferred stock, net	6,600,121	(16,241)
Preferred stock dividends paid in cash	(104,884)	0
Net cash provided by financing activities	10,320,063	3,273,312
Net change in cash and cash equivalents	1,242,750	2,386,511
Cash and cash equivalents at beginning of the period	254,705	966,183
Cash and cash equivalents at end of the period	1,497,455	3,352,694
Supplemental disclosure of cash flow information:
Cash paid for interest	284,437	198,572
Supplemental disclosure of non-cash investing and financing activity:
Deemed dividend on convertible preferred stock and accretion of discount	1,023,786	375,858
Preferred stock dividends paid or to be paid in common stock	578,178	276,693
Preferred stock issued to acquire "Bird & Cronin"	4,000,000	0
Acquisition holdback	2,147,291	0
Conversion of preferred stock to common stock	7,459,600	0
Accrued severance paid in common stock	$ 0	$ 185,000